GR1000437B - Διαμορφωσεις ανασταλτικου παραγοντος ενζυμου μετατροπης αγγειοτασινης - Google Patents
Διαμορφωσεις ανασταλτικου παραγοντος ενζυμου μετατροπης αγγειοτασινηςInfo
- Publication number
- GR1000437B GR1000437B GR890100710A GR890100710A GR1000437B GR 1000437 B GR1000437 B GR 1000437B GR 890100710 A GR890100710 A GR 890100710A GR 890100710 A GR890100710 A GR 890100710A GR 1000437 B GR1000437 B GR 1000437B
- Authority
- GR
- Greece
- Prior art keywords
- heterocyclic ring
- membered heterocyclic
- converting enzyme
- enzyme inhibitors
- angiotensin converting
- Prior art date
Links
- 239000005541 ACE inhibitor Substances 0.000 title 1
- 229940044094 angiotensin-converting-enzyme inhibitor Drugs 0.000 title 1
- 125000000623 heterocyclic group Chemical group 0.000 title 1
- 239000004480 active ingredient Substances 0.000 abstract 2
- 238000009472 formulation Methods 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 abstract 2
- -1 N- (1- (S) -ethoxycarbonyl-3-phenylpropyl) L-alanyl Chemical group 0.000 abstract 1
- 150000001408 amides Chemical class 0.000 abstract 1
- 239000002775 capsule Substances 0.000 abstract 1
- 238000007906 compression Methods 0.000 abstract 1
- 230000006835 compression Effects 0.000 abstract 1
- 239000003085 diluting agent Substances 0.000 abstract 1
- 150000002148 esters Chemical class 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Peptides Or Proteins (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB888825541A GB8825541D0 (en) | 1988-11-01 | 1988-11-01 | Formulation |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| GR890100710A GR890100710A (en) | 1990-12-31 |
| GR1000437B true GR1000437B (el) | 1992-07-30 |
Family
ID=10646121
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GR890100710A GR1000437B (el) | 1988-11-01 | 1989-10-31 | Διαμορφωσεις ανασταλτικου παραγοντος ενζυμου μετατροπης αγγειοτασινης |
Country Status (12)
| Country | Link |
|---|---|
| EP (1) | EP0367509A3 (de) |
| JP (1) | JPH02172917A (de) |
| BE (1) | BE1002966A5 (de) |
| CA (1) | CA2001906A1 (de) |
| CH (1) | CH679554A5 (de) |
| DK (1) | DK541789A (de) |
| FR (1) | FR2638642A1 (de) |
| GB (2) | GB8825541D0 (de) |
| GR (1) | GR1000437B (de) |
| IE (1) | IE893502L (de) |
| LU (1) | LU87616A1 (de) |
| PT (1) | PT92167A (de) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19544507B4 (de) | 1995-11-29 | 2007-11-15 | Novartis Ag | Cyclosporin enthaltende Präparate |
| SE9700135D0 (sv) † | 1997-01-20 | 1997-01-20 | Astra Ab | New formulation |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4178374A (en) * | 1974-08-16 | 1979-12-11 | Merck & Co., Inc. | Novel pharmaceutical compositions of β-blockers with diuretics |
| GB1590864A (en) * | 1978-05-16 | 1981-06-10 | Lilly Industries Ltd | Thixotropic filling medium for hard gelatin capsules |
| EP0105996A1 (de) * | 1982-10-15 | 1984-04-25 | Merck & Co. Inc. | Ophthalmische Zusammensetzung für die Behandlung von erhöhtem intraokularen Druck |
| ATE72431T1 (de) * | 1985-08-31 | 1992-02-15 | Fisons Plc | 5-gliedrige heterocyclische angiotensinumwandlungsenzym-inhibitoren. |
-
1988
- 1988-11-01 GB GB888825541A patent/GB8825541D0/en active Pending
-
1989
- 1989-10-27 GB GB8924207A patent/GB2224206B/en not_active Expired - Fee Related
- 1989-10-27 EP EP19890311096 patent/EP0367509A3/de not_active Withdrawn
- 1989-10-30 LU LU87616A patent/LU87616A1/fr unknown
- 1989-10-31 DK DK541789A patent/DK541789A/da not_active Application Discontinuation
- 1989-10-31 BE BE8901158A patent/BE1002966A5/fr not_active IP Right Cessation
- 1989-10-31 FR FR8914314A patent/FR2638642A1/fr not_active Withdrawn
- 1989-10-31 CA CA002001906A patent/CA2001906A1/en not_active Abandoned
- 1989-10-31 GR GR890100710A patent/GR1000437B/el unknown
- 1989-10-31 IE IE893502A patent/IE893502L/xx unknown
- 1989-10-31 PT PT92167A patent/PT92167A/pt unknown
- 1989-11-01 JP JP1283162A patent/JPH02172917A/ja active Pending
- 1989-11-01 CH CH3944/89A patent/CH679554A5/fr not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| CH679554A5 (de) | 1992-03-13 |
| GB8924207D0 (en) | 1989-12-13 |
| GR890100710A (en) | 1990-12-31 |
| DK541789D0 (da) | 1989-10-31 |
| GB2224206A (en) | 1990-05-02 |
| EP0367509A2 (de) | 1990-05-09 |
| DK541789A (da) | 1990-05-02 |
| PT92167A (pt) | 1990-05-31 |
| CA2001906A1 (en) | 1990-05-01 |
| GB2224206B (en) | 1992-12-09 |
| FR2638642A1 (fr) | 1990-05-11 |
| BE1002966A5 (fr) | 1991-10-08 |
| IE893502L (en) | 1990-05-01 |
| JPH02172917A (ja) | 1990-07-04 |
| GB8825541D0 (en) | 1988-12-07 |
| EP0367509A3 (de) | 1991-05-15 |
| LU87616A1 (fr) | 1991-07-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BG60102B2 (bg) | Метод за получаване на 5-флуор-2(((4-циклопропил- метокси-2-пиридинил)метил)тионил)-1н-бензимидазол | |
| HUP0004383A2 (hu) | Hatóanyagként klodronátot és vivőanyagként szilíciumozott mikrokristályos cellulózt tartalmazó gyógyszerészeti készítmény | |
| DE69522562D1 (de) | Eine glucagon enthaltende pharmazeutische zubereitung | |
| GB2303629B (en) | Hydroxamic acids and their use as metalloproteinase inhibitors | |
| DE69428040D1 (de) | Orale darreichungsform | |
| NO960949L (no) | Tablettert flerdoseenhetsform inneholdende protonpumpeinhibitor | |
| NO173998C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive benzimidazolderivater | |
| DE69125715D1 (de) | Heterozyklische verbindungen | |
| NO894616L (no) | Fremgangsmaate for fremstilling av anti-aterosklerotisk aktive diarylforbindelser. | |
| IT1270239B (it) | Composizione farmaceutica solida contenente acido (s)-2-(4- isobutilfenil) propionico come principio attivo | |
| FI913036A0 (fi) | Terapeutiskt aktiv substituerad benzimidazol och foerfarande foer dess framstaellning. | |
| ATE213633T1 (de) | Lamotrigin haltiges arzneimittel | |
| BG60101B2 (bg) | Метод за получаване на 4-флуор-2-(((4-метокси-2- пиридинил)метил)тионил)-1н-бензимидазол | |
| GR1000437B (el) | Διαμορφωσεις ανασταλτικου παραγοντος ενζυμου μετατροπης αγγειοτασινης | |
| FI891712A7 (fi) | Terapeuttisesti vaikuttavia syklometyleeni-1,2-bikarboksyylihappojen amiineja, menetelmiä niiden valmistamiseksi sekä niitä sisältäviä farmaseuttisia koostumuksia | |
| RU94040865A (ru) | Производные пептида и их терапевтически приемлемые соли, способ их получения, фармацевтическая и косметическая композиция с антивирусной активностью | |
| DE69522827D1 (de) | Fibrinogen receptor antagonisten mit substituierten b-aminosäurenestern und diese enthaltende pharmazeutische präparate | |
| EA200101157A1 (ru) | 14β-H-СТЕРОЛЫ, СОДЕРЖАЩИЕ ИХ ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ И ПРИМЕНЕНИЕ ЭТИХ ПРОИЗВОДНЫХ ДЛЯ ПРИГОТОВЛЕНИЯ ЛЕКАРСТВЕННЫХ СРЕДСТВ, РЕГУЛИРУЮЩИХ МЕЙОЗ | |
| ATE109981T1 (de) | Therapeutische mittel. | |
| CO4480761A1 (es) | Metodo para movilizar celulas tronco hematopoyeticas | |
| JO1881B1 (en) | Formula II for multi unit disc calibration | |
| RU96124097A (ru) | Активатор дифференцировки нервных клеток | |
| FI965153A0 (fi) | Metalloproteinaasi-inhibiittorit |